A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia

Gastroenterology

Volumn 124, Issue 3, 2003, Pages 651-659

  Paradis, Valérie ^a,b,f   Bièche, Ivan ^c,d   Dargère, Delphine ^b   Laurendeau, Ingrid ^c   Nectoux, Juliette ^c   Degott, Claude ^a   Belghiti, Jacques ^a   Vidaud, Michel ^c   Bedossa, Pierre ^b,e  

^a BEAUJON HOSPITAL   (France)

^b CNRS   (France)

^c Laboratoire de Pharmacognosie   (France)

^d CENTRE RENÉ HUGUENIN   (France)

^e BICÊTRE HOSPITAL   (France)

^f EUROPEAN SPACE AGENCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; GENE PRODUCT; MESSENGER RNA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NODULAR HYPERPLASIA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 0037371381     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.50104     Document Type: Article

References (33)

1. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975;59:995-1013.
2. Knowles DM, Wolff M. Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature. Hum Pathol 1976;7:533-545.
3. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5:1194-1200.
4. Kondo F. Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol 2001;16:1319-1328.
5. Scoazec JY, Flejou JF, D'Errico A, Couvelard A, Kozyraki R, Fiorentino M, Grigioni WF, Feldmann G. Focal nodular hyperplasia of the liver: composition of the extracellular matrix and expression of cell-cell and cell-matrix adhesion molecules. Hum Pathol 1995;26:1114-1125.
6. Ojanguren I, Ariza A, Castella EM, Fernandez-Vasalo A, Mate JL, Navas-Palacios JJ. p53 immunoreactivity in hepatocellular adenoma, focal nodular hyperplasia, cirrhosis and hepatocellular carcinoma. Histopathology 1995;26:63-68.
7. Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES. Immunohistochemical detection of bd bcl-2 protein in normal and pathological human liver. Am J Pathol 1994;144:460-465.
8. Paradis V, Laurent A, Flejou JF, Vidaud M, Bedossa P. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X chromosome inactivation. Hepatology 1997;26:891-895.
9. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996;14:457-460.
10. Chen JJ, Wu R, Yang PC, Huang JY, Sher YP, Han MH, Kao WC, Lee PJ, Chiu TF, Chang F, Chu YW, Wu CW, Peck K. Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection. Genomics 1998;51:313-324.
11. Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 2000;60:4161-4166.
12. Bieche I, Parfait B, Le Doussal V, Olivi M, Rio MC, Lidereau R, Vidaud M. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res 2000;61:1652-1658.
13. Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinomas. Cancer Res 2001;61:3176-3181.
14. Graveel CR, Jatkoe T, Madore SJ, Holt AL, Farnham PJ. Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene 2001;20:2704-2712.
15. Delpuech O, Trabut JB, Carnot F, Feuillard J, Brechot C, Kremsdorf D. Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma. Oncogene 2002;21:2926-2937.
16. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996;87:1161-1169.
17. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60.
18. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor during embryonic angiogenesis. Cell 1996;87:1171-1180.
19. Lie YS, Petropoulos CJ. Advances in quantitative PCR technology: 5′ nuclease assays. Curr Opin Biotechnol 1998;9:43-48.
20. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van de Water L, Senger DR. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991;174:1275-1278.
21. Folkman DJ, D'amore PA. Blood vessel formation: what is its molecular basis? Cell 1996;87:1153-1155.
22. Hanahan D, Folkman DJ. Patterns and emerging mechanisms of the angiogenic switch during tumorogenesis. Cell 1996;86:353364.
23. Jones N, Iljin K, Dumont DJ, Alitalo K. Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2001;2:257-267.
24. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000;6:460-463.
25. Suri C, McLain J, Thurston J, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. Increased vascularisation in mice overexpressing angiopoietin-1. Science 1998;282:468-471.
26. Tian S, Hayes AJ, Metheny-Barlow U, Li LY. Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1. Br J Cancer 2002;86:645-651.
27. Kuroda H, Ohtsuru A, Futakuchi M, Kawashita Y, Nagayama Y, Fukuda E, Namba H, Shirai T, Kanematsu T, Yamashita S. Distinctive gene expression of receptor-type tyrosine kinase families during rat hepatocarcinogenesis. Int J Mol Med 2002;9:473-480.
28. Tanaka S, Mori M, Sakamoto Y, Makuuchi M, Sugimachi K, Wands JR. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest. 1999;103:341-345.
29. Tanaka S, Sugimachi K, Yamashita Y, Ohga T, Shirabe S, Shimada M, Wands JR, Sugimachi K. Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma. Hepatology 2002;35:861-867.
30. Yu Q, Stamenkovic I. Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. Am J Pathol 2001;158:563-570.
31. Fabre A, Audet P, Vilgrain V, Nguyen BN, Valla D, Belghiti J, Degott C. Histologic scoring of liver biopsy in focal nodular hyperplasia with atypical presentation. Hepatology 2002;35:414-420.
32. Bioulac-Sage P, Balabaud C, Wanless IR. Diagnosis of focal nodular hyperplasia: not so easy. Am J Surg Pathol 2001;25:1322-1325.
33. Lepreux S, Laurent C, Balabaud C, Bioulac-Sage P. Focal nodular hyperplasia lacking some key histopathological features making the diagnosis difficult. Virchows Arch 2002;440:445-446.